Sleeping sickness finding could lead to earlier diagnosis

April 14, 2008

Sleeping sickness creates a metabolic 'fingerprint' in the blood and urine, which could enable a new test to be developed to diagnose the disease, according to new research published today in the journal Proceedings of the National Academy of Sciences.

Sleeping sickness, or human African trypanosomiasis, is usually fatal if it is not diagnosed and treated in time. The disease is newly detected in around 30,000 people in sub-Saharan Africa every year. Researchers estimate that the real number of cases is likely to be around ten times this number, as so few patients are accurately diagnosed.

Sleeping sickness is typically passed on through a bite from an infected tsetse fly, which transmits a subspecies of a parasite known as Trypanosoma brucei into the bloodstream.

The new study shows that, in a mouse model, infection with the parasite creates distinct metabolic 'fingerprints' in the blood and urine and that these fingerprints are different at different stages of the disease. This fingerprint was visible in the blood as early as one day after infection.

The researchers, from Imperial College London and institutions in Switzerland and the USA, hope that their findings could ultimately enable a fast and accurate test to be developed so that people can be tested and treated more quickly, improving their chances of survival.

Sleeping sickness is currently difficult to diagnose because its symptoms, which in its first stage include headache, weakness, and joint pain, are shared by many other conditions. The disease is found in over 20 countries in sub-Saharan Africa and doctors there rarely have the resources to carry out the necessary diagnostic tests or to treat infected cases.

Doctors have to use both a blood test and a lymphatic fluid test, using a needle inserted into the lymph node, in order to confirm a positive diagnosis. They then use a painful and invasive lumbar puncture to work out which stage the disease has reached, in order to select the best drug for treatment.

It is important to catch the disease as early as possible in order to give the patient a chance of recovering. In the second stage of the disease, when the parasite progresses into the patient's brain, doctors have to use a different, less effective set of drugs. One of these drugs, melarsoprol, can cause devastating side-effects, such as a brain disease, or encephalopathy, which causes fatality in 50 percent of cases.

Professor Elaine Holmes, corresponding author of the research from the Department of Biomolecular Medicine at Imperial College, said: "Sleeping sickness is a shattering disease and it is often not spotted until it is too late. Its initial symptoms can be quite mild and non-specific and doctors in sub-Saharan Africa don't usually have the time or money to carry out the tests to check if someone has it. This means a lot of people are dying and if there was a simpler way of testing people, doctors might be able to save many of them.

"Our research is at a very early stage, but our results suggest that scientists could in the future create a better way to test for sleeping sickness. So far we have only looked at a mouse model, and we have not yet investigated what happens when there are multiple parasites in the body, but these are promising findings," she added.

For the new study, the researchers used NMR spectroscopy to analyse the metabolic profiles of twelve mice infected with the parasite Trypanosoma brucei brucei, using blood and urine samples. They carried out their analyses two days before infection and at a series of points over a 33-day period after infection. Twelve uninfected mice acted as controls.

Trypanosoma brucei brucei cannot infect humans with sleeping sickness but it is very closely related to the parasites Trypanosoma brucei gambiense and Trypanosoma brucei rhodesiense, which do.

The next step for this research is to determine whether the findings in mouse models can be replicated in humans. The researchers also want to explore whether other parasitic infections create their own metabolic fingerprints, and how such fingerprints can be distinguished from one another where a person has multiple parasitic infections.

The researchers are also keen to investigate whether the parasite that causes sleeping sickness has become more virulent. In the current study, a separate group of mouse models was used to ascertain how quickly the disease progressed. This revealed that the parasite crossed into the brain much sooner than had been shown previously. Earlier studies had shown that the parasite was established in the brains of mouse and rat models 21 and 13 days after infection, respectively. The new study showed that the parasite crossed into the brain within seven days of infection.

Source: Imperial College London

Explore further: Study: Sleeping sickness not just a sleeping disorder

Related Stories

Study: Sleeping sickness not just a sleeping disorder

January 4, 2018
An international study from the Instituto de Medicina Molecular shows one of Africa's most lethal diseases is actually a circadian rhythm disorder caused by the acceleration of biological clocks controlling a range of vital ...

VA study shows parasite from Vietnam may be killing vets

November 21, 2017
A half century after serving in Vietnam, hundreds of veterans have a new reason to believe they may be dying from a silent bullet—test results show some men may have been infected by a slow-killing parasite while fighting ...

Health Department IDs 10 outbreaks of foodborne illness using Yelp reviews since 2012

January 10, 2018
A computer system developed by Columbia University with Health Department epidemiologists detects foodborne illness and outbreaks in NYC restaurants based on keywords in Yelp reviews

In Sao Tome, funding fears overshadow gains against malaria

December 12, 2017
A big roadside poster announces a "Pest Control Campaign" in Sao Tome and Principe, with a man in a white face mask wielding an insecticide spray fuelled by a tank on his back.

New tool in the fight against tropical diseases

February 26, 2013
A novel tool exploits baker's yeast to expedite the development of new drugs to fight multiple tropical diseases, including malaria, schistosomiasis, and African sleeping sickness. The unique screening method uses yeasts ...

Cancer-like forms of parasites may lead to new approaches to curing diseases

November 3, 2015
A study in the Proceedings of the National Academy of Sciences shows that some forms of the single celled parasites, Trypanosoma brucei and Toxoplasma gondii behave like cancer cells.

Recommended for you

Past encounters with the flu shape vaccine response

February 20, 2018
New research on why the influenza vaccine was only modestly effective in recent years shows that immune history with the flu influences a person's response to the vaccine.

Building better tiny kidneys to test drugs and help people avoid dialysis

February 16, 2018
A free online kidney atlas built by USC researchers empowers stem cell scientists everywhere to generate more human-like tiny kidneys for testing new drugs and creating renal replacement therapies.

Expanding Hepatitis C testing to all adults is cost-effective and improves outcomes

February 16, 2018
According to a new study, screening all adults for hepatitis C (HCV) is a cost-effective way to improve clinical outcomes of HCV and identify more infected people compared to current recommendations. Using a simulation model, ...

Study suggests expanded range for emerging tick-borne disease

February 16, 2018
Human cases of Borrelia miyamotoi, a tick-borne infection with some similarities to Lyme disease, were discovered in the eastern United States less than a decade ago. Now new research led by the Yale School of Public Health ...

IFN-mediated immunity to influenza A virus infection influenced by RIPK3 protein

February 15, 2018
Each year, influenza kills half a million people globally with the elderly and very young most often the victims. In fact, the Centers for Disease Control and Prevention reported 37 children have died in the United States ...

Flu shot only 36 percent effective, making bad year worse (Update)

February 15, 2018
The flu vaccine is doing a poor job protecting older Americans and others against the bug that's causing most illnesses.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.